drugset
drugset / Trial / NCT00574756

Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction

NCT00574756 ↗

Terminated 14 enrolled University of California, San Diego
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effects of ranolazine, an FDA-approved medication for the treatment of angina, on heart function by using echocardiography.

Timeline

Start
2007-12
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ranolazine Small molecule 500 mg —

Indications

diastolic heart failure